SCHEMBL23211682

SCHEMBL23211682

CC(=O)O[C@H]1C[C@H](n2cnc3c(=O)[nH]c(N)nc32)O[C@@H]1CO

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.54
POLB P06746 1/20 0.53
HPGD P15428 1/20 0.50
HINT1 P49773 2/20 0.48
POLA1 P09884 1/20 0.46
HPRT1 P00492 2/20 0.45
P2RY2 P41231 1/20 0.45
P2RY4 P51582 1/20 0.45
P2RY6 Q15077 1/20 0.45
STING1 Q86WV6 2/20 0.45
PDE3A Q14432 2/20 0.45
PDE3B Q13370 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
PNP P00491 1/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
HTT P42858 1/20 0.45
PDE4D Q08499 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8017969 0.91 KDM4E (0.51) KDM4EPOLBHPGDHINT1POLA1
SCHEMBL18769456 0.91 POLB (0.54) KDM4EPOLBHINT1P2RY2P2RY4
SCHEMBL17001491 0.91 POLB (0.54) KDM4EPOLBHINT1P2RY2P2RY4
SCHEMBL23352540 0.91 POLB (0.54) KDM4EPOLBHINT1P2RY2P2RY4
SCHEMBL3893075 0.91 POLB (0.54) KDM4EPOLBHINT1P2RY2P2RY4
SCHEMBL2775081 0.91 POLB (0.54) KDM4EPOLBHINT1P2RY2P2RY4
SCHEMBL31098063 0.90 KDM4E (0.58) KDM4EPOLBHPGDHINT1POLA1
SCHEMBL3279870 0.89 POLB (0.56) KDM4EPOLBHPGDHINT1POLA1
SCHEMBL16359975 0.89 POLB (0.56) KDM4EPOLBHPGDHINT1POLA1
SCHEMBL3279868 0.89 POLB (0.56) KDM4EPOLBHPGDHINT1POLA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161869-B2 Thermally-cleavable protecting and linker groups EVONETIX LTD. (GB) 2021-11-02 US disclosed
US-20210107934-A1 THERMALLY-CLEAVABLE PROTECTING AND LINKER GROUPS SILICON VALLEY BANK 2021-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210107934-A1 THERMALLY-CLEAVABLE PROTECTING AND LINKER GROUPS CTDSP1, RNGTT, SSU72 KDM4E 2740/4885POLB 24/4885HPGD 1514/4885
US-11161869-B2 Thermally-cleavable protecting and linker groups CTDSP1, RNGTT, SSU72 KDM4E 2740/4885POLB 24/4885HPGD 1514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.